Additional file 1 of Management and outcomes of myocardial infarction in people with impaired kidney function in England
Creators: name: Scott, Jemima
name: Bidulka, Patrick
name: Taylor, Dominic M.
name: Udayaraj, Udaya
name: Caskey, Fergus J.
name: Birnie, Kate
name: Deanfield, John
name: de Belder, Mark
name: Denaxas, Spiros
name: Weston, Clive
name: Adlam, David
name: Nitsch, Dorothea
Publisher: name: figshare
Year: 2024
Subjects: Medicine
Biological Sciences not elsewhere classified
Marine Biology
Cancer
Science Policy

description: Additional file 1: Additional table 1. Risk factors for CKD which fulfilled inclusion criteria for the NCKDA. Additional table 2. Details on linkages between study datasets. Additional table 3. ICD-10 codes for AMI identified in HES*. Additional table 4. CALIBER definition of AMI subtypes (STEMI, NSTEMI) using MINAP data.*. Additional table 5. Variables used to define death in-hospital and post-AMI discharge*. Additional table 6. Definitions for processes of AMI care in MINAP and HES datasets. Additional table 7. Details on data sources for covariates*. Additional table 8. Categorisation of PCI services available at each hospital in England for this study, derived from categorisation of PCI services available at each hospital in England by MINAP researchers. Additional table 9. Baseline characteristics of people with incomplete covariate data who are dropped from the complete case analysis (N=107). Additional table 10. Adjusted predicted percents for dying during the index AMI hospitalisation, and for receiving angiography and/or PCI during the index AMI hospitalisation, stratified by eGFR stage. Additional table 11. Other outcomes during the index AMI hospitalisation and post-AMI hospitalisation. Additional table 12. Death during the index AMI hospitalisation stratified by centre type. Additional table 13. Death post-AMI hospitalisation discharge, among people who survive the first AMI hospitalisation in the study period, stratified by AMI subtype and centre type. Additional table 14. Processes of care (angiography and/or PCI) associated with eGFR stage at baseline during the index AMI hospitalisation stratified by centre type in the overall population, and among people with STEMI hospitalisation only. Additional table 15. Processes of care (angiography and/or PCI) during the index AMI hospitalisation restricted to people with no previous AMI hospitalisation. Additional table 16. MDRD Study equation. Additional figure 1. Histogram describing the time between the most recent eGFR recorded in primary care (used to define baseline kidney function) and the index AMI hospitalisation. Additional figure 2. Processes of care (angiography and/or PCI) associated with eGFR stage at baseline during the index AMI hospitalisation stratified by prevalent type 2 diabetes mellitus (T2DM) and prevalent heart failure status. Additional figure 3. In-hospital death associated with eGFR stage at baseline during the index AMI hospitalisation stratified by prevalent type 2 diabetes mellitus (T2DM) and prevalent heart failure status. Additional figure 4. Death post-AMI discharge associated with eGFR stage at baseline during the index AMI hospitalisation stratified by prevalent type 2 diabetes mellitus (T2DM) and prevalent heart failure status.